These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9438158

  • 1. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I, Horváth S, Balázs C.
    Eur J Med Res; 1996 Sep 20; 1(11):543-6. PubMed ID: 9438158
    [Abstract] [Full Text] [Related]

  • 2. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I.
    Autoimmunity; 2007 Feb 20; 40(1):31-7. PubMed ID: 17364495
    [Abstract] [Full Text] [Related]

  • 3. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I, Bokk A.
    Cytokine; 2006 Aug 20; 35(3-4):109-14. PubMed ID: 17008110
    [Abstract] [Full Text] [Related]

  • 4. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM, Prummel MF, Wiersinga WM.
    Horm Metab Res; 2004 Jan 20; 36(1):44-7. PubMed ID: 14983406
    [Abstract] [Full Text] [Related]

  • 5. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Acta Med Hung; 1991 Jan 20; 48(1-2):13-21. PubMed ID: 1813853
    [Abstract] [Full Text] [Related]

  • 6. [An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease].
    Sato A, Yamada T.
    Nihon Rinsho; 1999 Aug 20; 57(8):1904-9. PubMed ID: 10483274
    [Abstract] [Full Text] [Related]

  • 7. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.
    Sayinalp S, Akalin S, Sayinalp N, Erbaş T, Bayraktar M, Ozcebe OI, Dündar S, Kirazli S.
    Horm Metab Res; 1996 Mar 20; 28(3):133-7. PubMed ID: 8926012
    [Abstract] [Full Text] [Related]

  • 8. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I.
    Horm Metab Res; 2001 Dec 20; 33(12):739-43. PubMed ID: 11753760
    [Abstract] [Full Text] [Related]

  • 9. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C, Kiss E.
    Acta Microbiol Immunol Hung; 1994 Dec 20; 41(4):451-6. PubMed ID: 7866729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov 20; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.